Serum dehydroepiandrosterone sulfate and osteoarthritis in older people: the Pro.V.A. study
- PMID: 26898983
- DOI: 10.1007/s10067-016-3213-1
Serum dehydroepiandrosterone sulfate and osteoarthritis in older people: the Pro.V.A. study
Abstract
Although osteoarthritis (OA) and low levels of dehydroepiandrosterone sulfate (DHEAS) are common in the elderly, no studies on human beings are available concerning the possible relationship between them. We aimed to examine the relationship between DHEAS levels and any presence of OA in a cohort of community-dwelling older subjects. This study was part of the Progetto Veneto Anziani (Pro.V.A.), an Italian population-based cohort study on people over 65 years old. In this cross-sectional work, we considered 2050 individuals with a mean age of 74.2 ± 7.1 years (818 M and 1232 F), and with a complete set of information on OA and DHEAS levels. OA was defined using a standardized algorithm investigating disease history, medical records, symptoms, use of analgesic drugs for OA, and physical examination of the hand, hip, and knee. DHEAS levels were classified using gender-specific tertiles. OA at the three sites investigated was significantly more common in women than in men, and in individuals with lower serum DHEAS concentrations. On logistic regression analysis, taking those in the highest DHEAS tertile for reference and adjusting for potential confounders, subjects in the lowest tertile had significantly higher odds of OA involving the hand (men: OR = 1.49; 95 % CI 1.31-1.70, women: 1.28; 95 % CI 1.16-1.41), hip (men: 1.55; 95 % CI 1.33-1.81; women: 1.17; 95 % CI 1.06-1.30), and knee (men: 1.54; 95 % CI 1.35-1.76; women: 1.31 95 % CI 1.19-1.45). Similar findings emerged for individuals in the intermediate DHEAS tertile. Low DHEAS levels are associated with OA, irrespective of site and gender.
Keywords: Community-dwelling adults; DHEAS; Elderly; Osteoarthritis.
Similar articles
-
Serum 25-Hydroxyvitamin D and Osteoarthritis in Older People: The Progetto Veneto Anziani Study.Rejuvenation Res. 2015 Dec;18(6):543-53. doi: 10.1089/rej.2015.1671. Epub 2015 Nov 5. Rejuvenation Res. 2015. PMID: 26540555
-
Serum Dehydroepiandrosterone Sulfate and Risk for Type 2 Diabetes in Older Men and Women: The Pro.V.A Study.Can J Diabetes. 2016 Apr;40(2):158-63. doi: 10.1016/j.jcjd.2015.09.013. Epub 2016 Feb 26. Can J Diabetes. 2016. PMID: 26923336 Clinical Trial.
-
Serum dehydroepiandrosterone sulfate and incident depression in the elderly: the Pro.V.A. study.Am J Geriatr Psychiatry. 2015 Aug;23(8):863-71. doi: 10.1016/j.jagp.2014.10.009. Epub 2014 Nov 6. Am J Geriatr Psychiatry. 2015. PMID: 25537161
-
Are low dehydroepiandrosterone sulphate levels predictive for cardiovascular diseases? A review of prospective and retrospective studies.Acta Cardiol. 2003 Oct;58(5):403-10. doi: 10.2143/AC.58.5.2005304. Acta Cardiol. 2003. PMID: 14609305 Review.
-
Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease.J Endocrinol. 1996 Sep;150 Suppl:S149-53. J Endocrinol. 1996. PMID: 8943798 Review.
Cited by
-
DHEA Inhibits Leukocyte Recruitment through Regulation of the Integrin Antagonist DEL-1.J Immunol. 2020 Mar 1;204(5):1214-1224. doi: 10.4049/jimmunol.1900746. Epub 2020 Jan 24. J Immunol. 2020. PMID: 31980574 Free PMC article.
-
Gender-Related Aspects in Osteoarthritis Development and Progression: A Review.Int J Mol Sci. 2022 Mar 2;23(5):2767. doi: 10.3390/ijms23052767. Int J Mol Sci. 2022. PMID: 35269906 Free PMC article. Review.
-
Sex Steroids and Osteoarthritis: A Mendelian Randomization Study.Front Endocrinol (Lausanne). 2021 Jun 23;12:683226. doi: 10.3389/fendo.2021.683226. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34248845 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical